Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
01 Dec 2014 07:00 AM
RNS
Oxford BioMedica plc Director's Share Purchase
28 Nov 2014 07:00 AM
RNS
Total Voting Rights
26 Nov 2014 07:00 AM
RNS
Director Dealings
03 Nov 2014 07:00 AM
RNS
Interim Management Statement
31 Oct 2014 07:00 AM
RNS
Total Voting Rights
17 Oct 2014 09:27 AM
RNS
Director's Interest in Share Options
17 Oct 2014 09:10 AM
RNS
Holding(s) in Company
16 Oct 2014 04:52 PM
RNS
Directorate Change
15 Oct 2014 05:05 PM
RNS
Holding(s) in Company
14 Oct 2014 07:00 AM
RNS
Oxford BioMedica plc Director's Share Purchase
13 Oct 2014 07:00 AM
RNS
Oxford BioMedica Acquires Windrush Court Office
10 Oct 2014 07:41 AM
RNS
Additional Listing
10 Oct 2014 07:00 AM
RNS
Second major agreement with Novartis
28 Aug 2014 07:00 AM
RNS
Half Yearly Report
15 Aug 2014 07:00 AM
RNS
Paul Blake Appointed as Chief Development Officer
07 Aug 2014 07:00 AM
RNS
Notice of Results
25 Jul 2014 09:48 AM
RNS
Block listing Application
01 Jul 2014 10:55 AM
RNS
Oxford BioMedica plc Director's Share Purchase
30 Jun 2014 07:00 AM
RNS
Total Voting Rights Update
23 Jun 2014 07:00 AM
RNS
Directors' Interest in Share Options
20 Jun 2014 02:38 PM
RNS
Piper Jaffray GenomeRx Symposium in New York
19 Jun 2014 09:50 AM
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19 Jun 2014 07:01 AM
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19 Jun 2014 07:00 AM
RNS
GRANT OF AWARDS
18 Jun 2014 11:30 AM
RNS
Loan Repayment in Full
18 Jun 2014 09:36 AM
RNS
Holding(s) in Company
18 Jun 2014 07:00 AM
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
16 Jun 2014 12:29 PM
RNS
RESULT OF GENERAL MEETING AND DIRECTORS DEALING
16 Jun 2014 07:00 AM
RNS
Results of firm fundraising and open offer
03 Jun 2014 12:34 PM
RNS
Result of AGM
29 May 2014 04:52 PM
RNS
Notice of posting of prospectus
29 May 2014 07:00 AM
RNS
Fundraising and Open Offer
22 May 2014 09:22 AM
RNS
Director Declaration
13 May 2014 07:00 AM
RNS
Interim Management Statement
02 May 2014 04:57 PM
RNS
2013 ANNUAL REPORT AND ACCOUNTS & AGM NOTIFICATION
30 Apr 2014 07:00 AM
RNS
?2.2 Million Grant Received from TSB
29 Apr 2014 07:00 AM
RNS
Oxford BioMedica provides update on RetinoStat?
10 Apr 2014 07:00 AM
RNS
Final Results
07 Apr 2014 07:00 AM
RNS
OXB completes patient recruitment into RetinoStat
03 Apr 2014 07:00 AM
RNS
Notice of Results
21 Mar 2014 07:00 AM
RNS
OXB Present at Regen Med Investor Day
17 Feb 2014 07:00 AM
RNS
Oxford BioMedica and Sanofi Amend Terms for Ocular
17 Jan 2014 04:40 PM
RNS
Second Price Monitoring Extn
17 Jan 2014 04:35 PM
RNS
Price Monitoring Extension
10 Jan 2014 07:00 AM
RNS
Publication of ProSavin Phase I/II Study
09 Jan 2014 12:19 PM
RNS
Oxford BioMedica to Present at Biotech Showcase
06 Jan 2014 10:28 AM
RNS
Oxford Biomedica PLC - General Meeting
18 Dec 2013 07:00 AM
RNS
OXB option agreement with GSK
11 Dec 2013 07:00 AM
RNS
CIRCULAR & GENERAL MEETING NOTIFICATION
22 Nov 2013 12:38 PM
RNS
Director/PDMR Shareholding

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100